The Problem

---

 “Because there is no cure for the common cold it gets far less attention than many less common conditions," Fendrick says. "An intervention that would effectively prevent or treat the cold would have a huge clinical and economic impact, far greater than for chronic diseases that we hear about on a regular basis.” 

http://www.webmd.com/cold-and-flu/news/20030224/cost-of-common-cold-40-billion#1

“The Cough and Cold Medicine Manufacturing OTC industry benefits from its high degree of public acceptance and use. For example, Americans contract an estimated 1.0 billion colds per year, which has maintained stable need-based demand for industry products. Furthermore, between 5.0% and 20.0% of the population contracts the flu each year.”

 https://www.ibisworld.com/industry/cough-cold-medicine-manufacturing-otc.html

$34-40 average OTC cost per cold incident in USA

With COVID-19 happening right now, everyone knows the impact a worldwide pandemic causes and the cost of this economically and socially. 

A flu pandemic is predicted to cost $60 billion USD every year https://www.who.int/influenza/spotlight CDC estimates that influenza, just in the US has resulted in between 9 million – 45 million illnesses, between 140,000 – 810,000 hospitalizations and between 12,000 – 61,000 deaths annually since 2010.  https://www.cdc.gov/flu/about/burden/index.html

“It doesn’t work: The Cochrane Database – an objective, gold-standard assessment of available evidence has plainly stated, in TWO STUDIES, that there is no data to support efficacy in children under two, and in adults.”  https://www.ncbi.nlm.nih.gov/pubmed/24623315  

Flu vaccines do not reduce hospitalization or days off work. 

Flu vaccines do not reduce hospitalization or days off work. 

http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD001269.pub5/abstract

“The  former Chief  Vaccine Officer at the FDA, Dr Anthony Morris, states  that there is no evidence that any influenza vaccine thus far developed  is effective in preventing or mitigating any attack of influenza.”

http://ahrp.org/john-anthony-morris-md/

https://www.hhs.gov/sites/default/files/nvpo/nvac/subgroups/hcpiv_individual_comments.pdf

• Reduce customer cost in OTC products from $34-40 down to $24 per cold incident
• Reduce number of cold symptoms
• Reduce number of sick days from average of 7-14 days to average of 24-72 hours
• Reduce risk for secondary infection from bacteria & yeast
• Significantly reduce $40+ billion burden on US economy & even more for the world community

• Reduce cost in OTC flu products from $52-$178 down to $24 per flu incident
• Reduce number of flu symptoms 
• Reduce number of sick days from an average of 14-21 days to an average of 24-72 hours
• Reduce risk for secondary infection from bacteria & yeast
• Significantly reduce $71-$167 billion burden on US economy & even more for the world community